Research study Program year 2025 Source: CMS Open Payments

A Randomized, Double-Blind, Phase 3 Comparison of Platinum-Based Thera

Research payments

$46,271,609

3,824 payments

Through program year 2025, $46,271,609 in research payments was reported against A Randomized, Double-Blind, Phase 3 Comparison of Platinum-Based Thera, across 3,824 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$2,162,935	418
2024	Research	$3,020,125	486
2023	Research	$6,191,033	631
2022	Research	$9,470,705	604
2021	Research	$10,168,916	804
2020	Research	$15,257,896	881

Breakdown

Who paid Research payments · program years 2020–2025

GlaxoSmithKline, LLC. $46,271,609 3,824 payments

Who received the money Research payments · program years 2020–2025

US Oncology Research LLC Organisation paid for research $11,661,000 744 payments
Bioclinica INC Organisation paid for research $3,914,532 248 payments
Womens Cancer Care Organisation paid for research $1,811,677 101 payments
University Of Rochester Organisation paid for research $1,694,230 35 payments
Swedish Health Services Organisation paid for research $1,571,739 73 payments
Board of Regents of the University of Oklahoma Organisation paid for research $1,337,215 57 payments
Research Foundation Of Suny Organisation paid for research $1,246,631 66 payments
Novant Health Presb Med Center Organisation paid for research $1,101,881 34 payments
Allegheny Singer Research Institute Organisation paid for research $866,008 67 payments
Avera McKennan Dba Organisation paid for research $798,928 47 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.